Immune privilege disruption in folliculotropic mycosis fungoides: Investigation of major histocompatibility complex antigen expression
International Journal of Dermatology Apr 10, 2018
Deonizio JMD, et al. - Researchers assessed a possible role of immune privilege (IP) in folliculotropic mycosis fungoides (FMF) analyzing the major histocompatibility complex (MHC) expression. The hypothesis of disruption of immune privilege based on the lower expression of HLA-G and higher expression of MHC-II in the follicular epithelium in mycosis fungoides vs alopecia areata and normal scalp skin was supported in the findings. Experts noted that the lack of difference between FMF and conventional mycosis fungoides (CMF) groups did not support the role of these molecules as a driver of folliculotropism. A difference in the expression of MHC molecules between neoplastic and inflammatory infiltrates was seen.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries